Salivary α-Amylase activity - A Novel non-invasive biomarker in clinical pathology

Abstract

Salivary biomarkers have developed into biological clinical research because they are accessible and easily obtained. Salivary α-Amylase was proposed as an associat marker of salivary cortisol in assessing stress and at the same time as a possible non-invasive indicator of autonomic nervous system activation. Studies conducted so far have tested α-Amylase activity in psychiatric disorders, diabetic neuropathy, lung disease, and autonomic nervous system activation in hypertension or heart failure.